Initial results of a drug checking pilot program to detect fentanyl adulteration in a Canadian setting

British Columbia Coroners Service, 2018

British Columbia Coroners Service, 2018

Fischer, 2018, The ‘fentanyl epidemic’ in Canada—some cautionary observations focusing on opioid-related mortality, Prev. Med., 107, 109, 10.1016/j.ypmed.2017.11.001

Frank, 2017, Addressing the fentanyl threat to public health, N. Engl. J. Med., 376, 605, 10.1056/NEJMp1615145

Giné, 2017, The utility of drug checking services as monitoring tools and more: a response to Pirona et al, Int. J. Drug Policy, 45, 46, 10.1016/j.drugpo.2017.05.018

Green, 2016, Counterfeit medications and fentanyl, JAMA Intern. Med., 176, 1555, 10.1001/jamainternmed.2016.4310

Hedegaard, 2017

Kennedy, 2018, Willingness to use drug checking within future supervised injection services among people who inject drugs in a mid-sized Canadian city, Drug Alcohol Depend., 185, 248, 10.1016/j.drugalcdep.2017.12.026

Kerr, 2017

Lysyshyn, 2017, Evaluation of a fentanyl drug checking program for clients of a supervised injection site

McGowan, 2018, Fentanyl self-testing outside supervised injection settings to prevent opioid overdose: do we know enough to promote it?, Int. J. Drug Policy, 58, 31, 10.1016/j.drugpo.2018.04.017

O’Donnell, 2017, Deaths involving fentanyl, fentanyl analogs, and U-47700–10 States, July–December 2016, MMRW Morb. Mortal. Wkly. Rep., 66, 1197, 10.15585/mmwr.mm6643e1

Quintana, 2017, The hidden web and the fentanyl problem: detection of ocfentanil as an adulterant in heroin, Int. J. Drug Policy, 40, 78, 10.1016/j.drugpo.2016.10.006

Sherman, 2018

Somerville, 2017, Characteristics of fentanyl overdose—Massachusetts, 2014-2016, MMWR Morb. Mortal. Wkly. Rep., 66, 382, 10.15585/mmwr.mm6614a2

Special Advisory Committee on the Epidemic of Opioid Overdoses, 2018